drugset / Trial / NCT02329756

Tranexamic Acid in Adherent Placenta (TAP)

NCT02329756

Phase 3 Withdrawn Baylor College of Medicine
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The objective of this study is to investigate the effect of tranexamic acid (TXA) administration on the outcome of cesarean-hysterectomy in women with suspected Morbidly Adherent Placenta (MAP; placenta accreta, increta, percreta).

Timeline

Start
2018-12
Primary completion
2020-12
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 1 g Intravenous

Indications